Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
AstraZeneca
Accenture
Medtronic
Chubb

Generated: May 22, 2019

DrugPatentWatch Database Preview

SIMULECT Drug Profile

« Back to Dashboard

Summary for Tradename: SIMULECT
Patents:100
Applicants:1
BLAs:1
Suppliers: see list1

US Patents for SIMULECT

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up Alexion Pharmaceuticals, Inc. (New Haven, CT) ➤ Sign Up RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up Actelion Pharmaceuticals Ltd. (Allschwil, CH) ➤ Sign Up RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up Actelion Pharmaceuticals Ltd. (Allschwil, CH) ➤ Sign Up RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up Actelion Pharmaceuticals Ltd. (Allschwil, CH) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for SIMULECT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
92780 Luxembourg ➤ Sign Up PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826
C01248802/01 Switzerland ➤ Sign Up PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: SWISSMEDIC 61521 15.12.2011
91902 Luxembourg ➤ Sign Up 91902, EXPIRES: 20260523
2011/036 Ireland ➤ Sign Up PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
UBS
Accenture
Deloitte
Daiichi Sankyo
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.